Aug 2026· Biomolecules· Vol 16, pp. 1175· 1 citation· 120 references
Medicine
TL;DR
Structural and functional aspects of PRC2 are described, with emphasis on the potential of this epigenetic context-dependent regulator to integrate developmental, environmental and aging-related signals, to shape the transcriptional landscape of aging brain.
Abstract
Brain aging is characterized by extensive and dynamic epigenetic changes that reshape chromatin architecture and influence gene regulatory networks, leading to deregulation of transcriptional programs essential for neuronal survival, synaptic plasticity, and cognitive function. Emerging studies highlight the pivotal regulatory role of the Polycomb Repressive Complex 2 (PRC2) in brain aging, functioning mainly as an epigenetic silencer through the establishment of the H3K27me3 histone mark at gene promoters and enhancers, leading to transcriptional repression. Altered distribution and decreased activity of PRC2 during aging disrupts the balance between gene activation and repression, affecting pathways involved in neurogenesis, synaptic plasticity and stress response. Further interplay with other epigenetic regulators such as histone deacetylase 2 (HDAC2), DNA methyltransferases and non-coding RNAs forms an extensive network that contributes to cognitive decline, increasing vulnerability for neurodegeneration. In this review, we describe structural and functional aspects of PRC2, with emphasis on the potential of this epigenetic context-dependent regulator to integrate developmental, environmental and aging-related signals, to shape the transcriptional landscape of aging brain. We also discuss the newly developed PRC2-AgeIndex, which serves as a prognostic biomarker for age-related neurodegeneration and monitoring treatment response, as well as current PRC2-targeting options for healthy brain aging.
Abnormal epigenetic modifications are involved in central nervous system (CNS) diseases. Histones play a crucial role in chromatin structure and function, whose post-translational modifications significantly impact gene expression and chromatin dynamics. Histone acetylation, governed by the balance between histone acet...
Xiao-Ming Xin, Ling-Juan Wu, Mei-Chen Liu et al.· Frontiers in Molecular Neuro...· 0 citations
It is suggested that the interaction between epigenetic and epitranscriptomic mechanisms is a key factor in determining risk and resilience for neuropsychiatric disorders, and offers new directions for future research and therapy development.
Y. Dwivedi, B. Roy· Brain : a journal of neurolo...· 0 citations
Although EZH2 expression is not consistently associated with overall survival in GBM, EZH2 remains a promising therapeutic target due to its roles in stemness and treatment resistance and its complex functions and therapeutic potential.
J. Grzegorzewski, M. Lindner, Dagmara Lisińska et al.· International Journal of Mol...· 0 citations
Nucleoporin-dependent regulation of neuronal responsiveness is identified, in which Nup153 represses neuronal genes including activity-regulated genes (ARGs), in the basal state, by characterizing the genome-wide landscape of chromatin accessibility, histone modifications and Nup153 chromatin binding.
Abhinav Soni, S. Petridi, Maria Ludovica Sforza et al.· bioRxiv· 0 citations
A unified mechanistic framework by which the level of YAP/TAZ activity determines enhancer landscapes that favor either differentiated or progenitor-like cellular states is proposed, providing a potential basis for applications to regenerative medicine and therapeutic interventions.
Ju-Gyeong Kang, Taejun Seol, Younghoon Kim et al.· Cold Spring Harbor Perspecti...· 0 citations
It is shown that neuronal activation triggers genome-wide redistribution of CBP and p300 in hippocampal neurons, and KAT3 redistribution is identified as a key mechanism coupling neuronal activity to large-scale chromatin remodeling.
S. Niñerola, Beatriz del Blanco, Mirjam Cangonja et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.